9 Einträge gefunden

1. Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial

   1. Minnema, Monique C
   2. Nasserinejad, Kazem
   3. Hazenberg, Bouke
   4. Hegenbart, Ute
   5. Vlummens, Philip
   6. Ypma, Paula F
   7. Kröger, Nicolaus

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
2. Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.

   1. Wolschke, Christine
   2. Stübig, Thomas
   3. Hegenbart, Ute
   4. Schönland, Stefan
   5. Heinzelmann, Marion
   6. Hildebrandt, York
   7. Ayuketang Ayuk, Francis

   2013 - Forschungsinformationssystem des UKE
3. Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study

   1. Gahrton, Gösta
   2. Iacobelli, Simona
   3. Björkstrand, Bo
   4. Hegenbart, Ute
   5. Gruber, Astrid
   6. Greinix, Hildegard
   7. Volin, Liisa

   2013 - Forschungsinformationssystem des UKE
4. Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

   1. Bornhäuser, Martin
   2. Kienast, Joachim
   3. Trenschel, Rudolf
   4. Burchert, Andreas
   5. Hegenbart, Ute
   6. Stadler, Michael
   7. Baurmann, Herrad

   2012 - Forschungsinformationssystem des UKE
5. Donor lymphocyte infusions in amyloid light chain amyloidosis: induction of a "graft-versus-plasma cell-dyscrasia effect".

   1. Schonland, Stefan O
   2. Kröger, Nicolaus
   3. Wolschke, Christine
   4. Dreger, Peter
   5. Ho, Anthony D
   6. Hegenbart, Ute

   2009 - Forschungsinformationssystem des UKE - frei zugänglich
6. Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation.

   1. Perz, Jolanta B
   2. Hegenbart, Ute
   3. Kröger, Nicolaus
   4. Otto, Gerd
   5. Ho, Anthony D
   6. Dreger, Peter

   2009 - Forschungsinformationssystem des UKE - frei zugänglich
7. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.

   1. Gahrton, Gösta
   2. Iacobelli, Simona
   3. Bandini, Giuseppe
   4. Björkstrand, Bo
   5. Corradini, Paolo
   6. Crawley, Charles
   7. Hegenbart, Ute

   2007 - Forschungsinformationssystem des UKE - frei zugänglich
8. Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.

   1. Donk, van de
   2. Kröger, Nicolaus
   3. Kröger, Nicolaus
   4. Hegenbart, Ute
   5. Corradini, Paolo
   6. Miguel, San
   7. Jesus, F

   2006 - Forschungsinformationssystem des UKE
9. Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.

   1. Schönland, Stefan O
   2. Lokhorst, Henk
   3. Buzyn, Agnes
   4. Leblond, Veronique
   5. Hegenbart, Ute
   6. Bandini, Giuseppe
   7. Campbell, Andrew

   2006 - Forschungsinformationssystem des UKE